Summary: Exercise of governmental authority to control conduct.
Publications260 found, 100 shown here
- The case for OFSMOKE: how tobacco price regulation is needed to promote the health of markets, government revenue and the publicAnna B Gilmore
Department for Health, University of Bath, Claverton Down, Bath BA27AY, UK
Tob Control 19:423-30. 2010..The paper outlines in some detail how such a system might be developed in the UK, while briefly exploring how it could be applied elsewhere, including in markets with state monopolies...
- Calorie labeling and food choices: a first look at the effects on low-income people in New York CityBrian Elbel
Division of General Internal Medicine at New York University School of Medicine and NYU Wagner School of Public Service, New York City, USA
Health Aff (Millwood) 28:w1110-21. 2009..However, we did not detect a change in calories purchased after the introduction of calorie labeling. We encourage more research on menu labeling and greater attention to evaluating and implementing other obesity-related policies...
- How effective is the revised regulatory code for alcohol advertising in Australia?Sandra C Jones
Centre for Health Initiatives, University of Wollongong, Australia
Drug Alcohol Rev 27:29-38. 2008..Following a formal review in 2003, the Ministerial Council on Drug Strategy proposed a revised Alcoholic Beverages Advertising Code (ABAC), which came into operation in 2004...
- Informed consent, anticipatory regulation and ethnographic practiceElizabeth Murphy
University of Nottingham, Nottingham, UK
Soc Sci Med 65:2223-34. 2007..We conclude the paper with a number of suggestions about how such professional models might be implemented...
- Why do people cooperate with medical research? Findings from three studiesMary Dixon-Woods
University of Leicester, Leicester, United Kingdom
Soc Sci Med 68:2215-22. 2009..Attention to the institutional context of research is critical to understanding what makes cooperation possible, and has important implications for the design of regulatory regimes for research...
- A review of public opinion towards alcohol controls in AustraliaClaire Tobin
Department of Health and Social Science, School of Public Health and Preventive Medicine, Monash University, PO Box 197 Caulfield East, Victoria 3145 Australia
BMC Public Health 11:58. 2011..This paper reviews levels of and trends in public support for liquor control regulations, regulation of alcohol promotions, and alcohol pricing and taxation reforms in Australia between 1998 and 2009...
- Declining sex ratio: role of society, technology and government regulation in Faridabad district, HaryanaA Bardia
Centre for Community Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India
Natl Med J India 17:207-11. 2004..a male child, awareness and acceptability of the practice of sex determination), technology (availability and affordability) and government regulation in the adverse ratio for girls in the Ballabgarh block of Haryana in northern India.
- Regulating health care in low- and middle-income countries: Broadening the policy response in resource constrained environmentsTim Ensor
Oxford Policy Management, UK
Soc Sci Med 65:355-66. 2007....
- [Government regulation of the private health care market in Brazil: a history of disputes]Eurípedes Balsanufo Carvalho
Hospital do Servidor Publico Estadual de Sao Paulo, Sao Paulo, Brasil
Cad Saude Publica 23:2167-77. 2007....
- Lead exposure, lead poisoning, and lead regulatory standards in China, 1990-2005Xibiao Ye
Fudan University School of Public Health, Shanghai, China
Regul Toxicol Pharmacol 46:157-62. 2006..The 2002 Act, without the necessary enforcement, did not appear to have a major impact on either lead exposures or lead poisoning in China. Much work in enforcing the 2002 Act remains to be done...
- Tobacco: a product like any other?Kirill Danishevskiy
ATACA Anti Tobacco Advocacy Coalition, Moscow, Russia
Health Econ Policy Law 6:265-72. 2011..We argue that the only way to redress this situation is to recognize that tobacco production and sales must be regulated in the same way as any other harmful and addictive substance...
- Medicine prices in urban Mozambique: a public health and economic study of pharmaceutical markets and price determinants in low-income settingsGiuliano Russo
Instituto de Higiene e Medicina Tropical, Rua da Junqueira 96, 1349 008 Lisbon, Portugal
Health Policy Plan 25:70-84. 2010..We also argue that price controls may not be the most effective way to influence access to medicines in low-income countries, and managing demand and supply towards cheaper effective drugs appears a more suitable policy option...
- Influence of pesticide regulation on acute poisoning deaths in Sri LankaDarren M Roberts
Division of Medicine, Royal Brisbane Hospital, Queensland, Australia
Bull World Health Organ 81:789-98. 2003..These regulations, which were implemented in Sri Lanka from the 1970s, aimed to reduce the number of deaths - the majority from self-poisoning - by limiting the availability and use of highly toxic pesticides...
- FDA regulation of stem-cell-based therapiesDina Gould Halme
School of Medicine, University of California at San Francisco, San Francisco, USA
N Engl J Med 355:1730-5. 2006
- The unintended consequences of clinical trials regulationsAlex D McMahon
Dental School, Faculty of Medicine, University of Glasgow, Glasgow, Scotland
PLoS Med 3:e1000131. 2009..Alex McMahon and colleagues critique the International Conference on Harmonisation (ICH) guidance on good clinical practice (GCP), arguing that it is having a disastrous effect on noncommerical randomized clinical trials in Europe...
- The effectiveness of limiting alcohol outlet density as a means of reducing excessive alcohol consumption and alcohol-related harmsCarla Alexia Campbell
Community Guide Branch of the National Center for Health Marketing, CDC, Atlanta, Georgia 30333, USA
Am J Prev Med 37:556-69. 2009..Primary evidence was supported by secondary evidence from correlational studies. The regulation of alcohol outlet density may be a useful public health tool for the reduction of excessive alcohol consumption and related harms...
- Evaluation of carcinogenic hazard of diesel engine exhaust needs to consider revolutionary changes in diesel technologyRoger O McClellan
Toxicology and Risk Analysis, 13701 Quaking Aspen Place NE, Albuquerque, NM 87111, USA
Regul Toxicol Pharmacol 63:225-58. 2012..We recommend that future reviews of carcinogenic hazards of diesel exhaust evaluate NTDE separately from TDE...
- Drug shop regulation and malaria treatment in Tanzania--why do shops break the rules, and does it matter?Catherine Goodman
Health Policy Unit, London School of Hygiene and Tropical Medicine, London, UK
Health Policy Plan 22:393-403. 2007..Such a change in approach has the potential to provide a firmer platform for public-private collaboration to improve shop-based treatment...
- Ambient air pollution: health hazards to childrenJanice J Kim
Pediatrics 114:1699-707. 2004....
- Tobacco industry manipulation of researchLisa A Bero
Department of Clinical Pharmacy, School of Pharmacy, Institute for Health Policy Studies, University of California, San Francisco 94143, USA
Public Health Rep 120:200-8. 2005
- Naturally occurring asbestos: a recurring public policy challengeR J Lee
RJ Lee Group Inc, Monroeville, PA 15146, USA
J Hazard Mater 153:1-21. 2008....
- The interplay of public health law and industry self-regulation: the case of sugar-sweetened beverage sales in schoolsMichelle M Mello
Department of Health Policy and Management, Harvard School of Public Health, 677 Huntington Ave, Boston, MA 02115, USA
Am J Public Health 98:595-604. 2008....
- Choosing health? First choose your philosophyMartin McKee
Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London WC1E 7 hT, UK
Lancet 365:369-71. 2005
- The health benefits of reduced tropospheric ozone in CaliforniaBart D Ostro
Office of Environmental Health Hazard Assessment, California Environmental Protection Agency, Oakland, CA 94612, USA
J Air Waste Manag Assoc 56:1007-21. 2006....
- European Clinical Trials Directive: responses made to MHRA consultation letter MLX 287David J Flavell
Lancet 362:1415. 2003
- The birth of the e-clinic. Continuity or transformation in the UK governance of pharmaceutical consumption?Nick Fox
ScHARR, University of Sheffield, Regent Court, 30 Regent Street, Sheffield S1 4DA, UK
Soc Sci Med 61:1474-84. 2005..This continuity can be explained by Rosenau's (Along the Domestic-Foreign Frontier. Cambridge University Press, Cambridge, 1997) model of a contested and fragmenting process of technology governance...
- Manufacturing uncertainty: contested science and the protection of the public's health and environmentDavid Michaels
Department of Environmental and Occupational Health, George Washington University School of Public Health and Health Services, 2100 M St NW, Suite 203, Washington, DC 20037, USA
Am J Public Health 95:S39-48. 2005..The public health system must ensure that scientific evidence is evaluated in a manner that assures the public's health and environment will be adequately protected...
- Regulatory parallels to Daubert: stakeholder influence, "sound science," and the delayed adoption of health-protective standardsRoni A Neff
Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Room E6636, Baltimore, MD 21205, USA
Am J Public Health 95:S81-91. 2005..Most recently, political tampering with science provides the foundation for some policymakers to disregard science completely in the environmental regulatory process...
- Perspectives on human stem cell researchKyu Won Jung
Law School, Hanyang University, 17 Haengdang dong, Seongdong Gu, Seoul 133 791, South Korea
J Cell Physiol 220:535-7. 2009..We do not need to exclude any type of stem cell research because each has its own merits and issues, and they can facilitate the scientific revolution when working together...
- Commercialism, choice and consumer protection: regulation of complementary medicines in AustraliaKen J Harvey
School of Public Health, La Trobe University, Melbourne, Vic, Australia
Med J Aust 188:21-5. 2008..Complaint procedures (now overloaded) are no substitute for adequate regulation at the time of market entry. Regulatory reform of listed and homoeopathic products is required...
- Scientific and legal perspectives on science generated for regulatory activitiesCarol J Henry
American Chemistry Council, Arlington, Virginia, USA
Environ Health Perspect 116:136-41. 2008..In a closely related example, the U.S. Environmental Protection Agency considered but abandoned a program to implement standards aimed at "external" information...
- Learning the value of drugs--is rofecoxib a regulatory success story?Rebecca S Eisenberg
University of Michigan Law School, Ann Arbor, USA
N Engl J Med 352:1285-7. 2005
- Modern regulatory impact analysis: the experience of the European UnionBruce Ballantine
Business Decisions Limited, Heronswood House, Maidstone Road, Pembury, Kent TN2 4DD, UK
Regul Toxicol Pharmacol 44:57-68. 2006..The paper finally draws a number of conclusions and makes a number of recommendations for further improvements in the quality of the regulatory process in the European Union...
- A legal framework for preventing cardiovascular diseasesWendy C Perdue
Georgetown University Law Center, Washington, DC 20001, USA
Am J Prev Med 29:139-45. 2005..Examples of key roles that health professionals can play in advancing such an understanding are presented...
- Use of transgenic mice in carcinogenicity hazard assessmentDavid Jacobson-Kram
Office of New Drugs, Center for Drug Evaluation and Research, U S Food and Drug Administration, Rockville, Maryland 20850, USA
Toxicol Pathol 32:49-52. 2004..This presentation reviews the current state of the science and its application to regulatory issues...
- Organophosphate exposures in the United States: a longitudinal analysis of incidents reported to poison centersDaniel L Sudakin
Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, Oregon 97331 6502, USA
J Toxicol Environ Health A 70:141-7. 2007..The results of this investigation are consistent with other studies that have reported that regulatory restriction of access to pesticide formulations may have a significant impact on the number of human exposure incidents...
- Environmental pediatrics and its impact on government health policyLynn Goldman
Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 20815, USA
Pediatrics 113:1146-57. 2004..More recently, these issues have been taken up by states and in the international arena...
- Understanding Philip Morris's pursuit of US government regulation of tobaccoP A McDaniel
Center for Tobacco Control Research and Education, University of California, San Francisco, 530 Parnassus Avenue, Suite 366, San Francisco, CA 94143 1390, USA
Tob Control 14:193-200. 2005..To investigate Philip Morris's support of US Food and Drug Administration (FDA) regulation of tobacco products and analyse its relationship to the company's image enhancement strategies...
- Decline in hospitalisations due to dog bite injuries in Catalonia, 1997-2008. An effect of government regulation?Joan R Villalbí
Agència de Salut Pública de Barcelona, Barcelona, Spain
Inj Prev 16:408-10. 2010..To analyse population-based data on hospitalisation caused by dog bite injuries after changes in legal regulations on dog ownership, including breed-specific regulations...
- The creation of industry front groups: the tobacco industry and "get government off our back"Dorie E Apollonio
Department of Clinical Pharmacy, University of California San Francisco, San Francisco, CA 94143, USA
Am J Public Health 97:419-27. 2007..Those who seek to establish measures to protect public health should be prepared to counter the argument that government should not regulate private behavior...
- Government regulation of sex and sexuality: in their own wordsSofia Gruskin
Department of Global Health and Population, Harvard School of Public Health, Boston, MA, USA
Reprod Health Matters 17:108-18. 2009....
- Perceived justice and popular support for public health laws: a case study around comprehensive smoke-free legislation in Mexico CityJames F Thrasher
Department of Health Promotion, Education and Behavior, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA
Soc Sci Med 70:787-93. 2010....
- Legislating "sound science": the role of the tobacco industryAnnamaria Baba
Department of Clinical Pharmacy, University of California, San Francisco, 3333 California Street, Suite 420, Box 0613, San Francisco, CA 94143, USA
Am J Public Health 95:S20-7. 2005..The tobacco industry played a role in establishing laws that increase corporate influence on public health and regulatory policy decisions...
- Child care as an untapped setting for obesity prevention: state child care licensing regulations related to nutrition, physical activity, and media use for preschool-aged children in the United StatesKaren M Kaphingst
Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, 1300 S 2nd St, Ste 300, Minneapolis, MN 55454, USA
Prev Chronic Dis 6:A11. 2009..6 million preschool-aged children participated in child care in 2001. Each US state creates and enforces its own child care licensing regulations. We analyzed obesity-related child care licensing regulations of US states...
- Unregulated private markets for health care in Canada? Rules of professional misconduct, physician kickbacks and physician self-referralSujit Choudhry
Faculty of Law, University of Toronto, ON
CMAJ 170:1115-8. 2004
- A regulatory patchwork--human ES cell research oversightLori P Knowles
Health Law Institute, University of Alberta, Canada
Nat Biotechnol 22:157-63. 2004
- Ten years of judicial gatekeeping under DaubertJoe S Cecil
Federal Judicial Center s Program on Scientific and Technical Evidence, One Columbus Circle, NE, Washington, DC 20002, USA
Am J Public Health 95:S74-80. 2005..Future research should focus on the pretrial screening of expert testimony and interactions between the attorneys and experts in shaping that testimony...
- Quantifying the federal minimal risk standard: implications for pediatric research without a prospect of direct benefitDavid Wendler
Department of Clinical Bioethics, NIH Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA
JAMA 294:826-32. 2005..These data also raise the question of whether the federal minimal risk standard may sometimes fail to provide sufficient protection for children, prompting the need to consider alternative standards...
- New federal guidelines for physician-pharmaceutical industry relations: the politics of policy formationSusan Chimonas
Center on Medicine as a Profession CMAP, College of Physicians and Surgeons, Columbia University, New York, NY, USA
Health Aff (Millwood) 24:949-60. 2005..We also explore the implications--some intended, others unanticipated--of the final document...
- Daubert's menaceGio Batta Gori
Am J Public Health 96:206; discussion 206-7. 2006
- Law's knowledge: science for justice in legal settingsSheila Jasanoff
John F Kennedy School of Government, School of Public Health, Department of the History of Science, Harvard University, 79 JFK Street, Room L354, Boston, MA, USA
Am J Public Health 95:S49-58. 2005..The important question for the law is not how judges can best do justice to science, but rather how courts can better render justice under conditions of uncertainty and ignorance...
- The perils of relying on interested parties to evaluate scientific qualityWendy Wagner
University of Texas School of Law, 727 East Dean Keeton Street, Austin, TX 78705 3299, USA
Am J Public Health 95:S99-106. 2005....
- What has a decade of Daubert wrought?Margaret A Berger
Brooklyn Law School, 250 Joralemon Street, Room 911, Brooklyn, NY 11201, USA
Am J Public Health 95:S59-65. 2005..expert witnesses? What do we know about Daubert's impact on improving science in the court room? What has been Daubert's effect on access to the courts? Does Daubert further public policy objectives of protecting the public against harm?..
- Philip Morris' FDA gambit: good for public health?Michael Givel
Department of Political Science, The University of Oklahoma, 455 West Lindsey, Room 2I7, Norman, USA
J Public Health Policy 26:450-68. 2005..On the other hand, tobacco products would have remained a politically and economically viable and legal product consumed by millions of Americans many of whom would have continued to suffer from tobacco-related illnesses and deaths...
- The case for preemption of prescription drug failure-to-warn claimsChristine H Kim
Food Drug Law J 62:399-422. 2007
- Diversionary reframing of the Great Lakes Water Quality AgreementMichael Gilbertson
Occupational and Environmental Health Research Group, Stirling University, Scotland, UK
J Public Health Policy 28:201-15. 2007..The scientific evidence of continuing injury to health and property from trans-boundary pollution convinces us that this reframing is an unwarranted diversion from the original intent...
- Drug risks and free speech--can Congress ban consumer drug ads?Miriam Shuchman
N Engl J Med 356:2236-9. 2007
- The impact of the cox-2 inhibitor issue on perceptions of the pharmaceutical industry: content analysis and communication implicationsRagnar E Lofstedt
King s Centre for Risk Management, King s College London, London, England
J Health Commun 12:471-91. 2007....
- Death at a discount: how the tobacco industry thwarted tobacco control policies in US military commissariesElizabeth A Smith
Department of Social and Behavioral Sciences, University of California, San Francisco, Box 0612 San Francisco, CA 94143 0612, USA
Tob Control 16:38-46. 2007..Tobacco use also impairs short-term troop readiness...
- Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debateHoward L Dorfman
Bayer HealthCare LLC, West Haven, CT, USA
Food Drug Law J 61:585-622. 2006
- A history of drug advertising: the evolving roles of consumers and consumer protectionJulie Donohue
University of Pittsburgh, Graduate School of Public Health, Department of Health Policy and Management, 130 DeSoto Street, Crabtree Hall A613, Pittsburgh, PA 15261, USA
Milbank Q 84:659-99. 2006....
- Pharmaceutical marketing practices: balancing public health and law enforcement interests; moving beyond regulation-through-litigationChristopher D Zalesky
World Wide Health Care Compliance, Johnson and Johnson, USA
J Health Law 39:235-64. 2006..This approach borrows lessons learned from the FDA's efficient and effective regulatory and enforcement methods and maintains a careful balance between the interests of patient-beneficiaries, the government and industry...
- Privacy and policy for genetic researchJudith Wagner DeCew
Department of Philosophy, Clark University, 950 Main Street, Worcester, MA 01610, USA
Ethics Inf Technol 6:5-14. 2004....
- Obesity--the new frontier of public health lawMichelle M Mello
Department of Health Policy and Management, Harvard School of Public Health, Boston, USA
N Engl J Med 354:2601-10. 2006
- The pharmaceutical industry's responsibility for protecting human subjects of clinical trials in developing nationsFinnuala Kelleher
Columbia Journal of Law and Social Problems, Columbia University, USA
Columbia J Law Soc Probl 38:67-106. 2004....
- From Asilomar to industrial biotechnology: risks, reductionism and regulationSheldon Krimsky
Department of Urban and Environmental Policy and Planning, Tufts University, Medford, MA 02155, USA
Sci Cult (Lond) 14:309-23. 2005
- Rights, patents, markets and the global AIDS pandemicJames Thuo Gathii
Albany Law School, USA
Fla J Int Law 14:261-352. 2002
- Neoliberal and public health effects of failing to adopt OSHA's national secondhand tobacco smoke ruleMichael Givel
Department of Political Science, The University of Oklahoma, Norman 73109, USA
Int J Health Serv 36:137-55. 2006....
- Ethics and policy perspectives on personalized medicine in the post-genomic eraMelissa R Landon
Boston University, USA
J Biolaw Bus 8:28-36. 2005....
- Legal developments relevant to FDA authorityDaniel Meron
Department of Health and Human Services, USA
Food Drug Law J 62:441-4. 2007
- Protecting research subjects--the crisis at Johns HopkinsRobert Steinbrook
N Engl J Med 346:716-20. 2002
- Senators grill NIH director over restrictions on stem-cell researchJeffrey Brainard
Chron High Educ 49:A25. 2003
- The federal preemption debate in pharmaceutical labeling product liability actionsJodie M Gross
Harris Beach PLLC, New York, New York, USA
Tort Trial Insur Pract Law J 43:35-70. 2007
- Dipping into Uncle Sam's pockets: federal funding of stem cell research: is it legal?Carly Goldstein
Boston Univ Public Interest Law J 11:229-59. 2002
- Taking another look at the definition of an embryo: President Bush's criteria and the problematic application of federal regulations to human embryonic stem cellsSimon B Auerbach
Emory University School of Law, Atlanta, Georgia, USA
Emory Law J 51:1557-604. 2002
- Liability for institutional review boards: from regulation to litigationDavid B Resnik
The Brody School of Medicine at East Carolina University, Greenville, North Carolina, USA
J Leg Med 25:131-84. 2004
- Triage in the nation's medicine cabinet: the puzzling scarcity of vaccines and other drugsLars Noah
University of Florida, P O Box 117625, Gainesville, FL 32611 7625, USA
S C Law Rev 54:371-403. 2002..Otherwise, patients may continue to lose access to important therapeutic products...
- A comprehensive national policy to stop human cloning: an analysis of the Human Cloning Prohibition Act of 2001 with recommendations for federal and state legislaturesShawn E Peterson
Notre Dame Law School, USA
Notre Dame J Law Ethics Public Policy 17:217-68. 2003
- Experts warn drug industry, government about weaknesses in drug supply chainDonna Young
Am J Health Syst Pharm 60:2176, 2180, 2184. 2003
- Private wealth and public health: a critique of Richard Epstein's defense of the "old" public healthWilliam J Novak
Department of History, University of Chicago, 1126 East 59th Street, Chicago, IL 60637, USA
Perspect Biol Med 46:S176-98. 2003....
- Children in clinical research: a conflict of moral valuesVera Hassner Sharav
The Alliance for Human Research Protection
Am J Bioeth 3:W-IF 2. 2003....
- Cloning and stem cells--handicapping the political and scientific debatesGeorge Q Daley
Whitehead Institute for Biomedical Research, Cambridge, USA
N Engl J Med 349:211-2. 2003
- The need for FDA regulation of tobacco productsEdward M Kennedy
Yale J Health Policy Law Ethics 3:101-8. 2002
- Clinical trials face heightened scrutiny as science and commerce appear to mergeAlvin J Lorman
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, USA
J Biolaw Bus 4:23-32. 2001..The risk of increased government involvement includes criminal prosecution of physicians for failing to follow the rules, as an innovative case in California demonstrates...
- Molecular diagnostics: an FDA perspectiveAli M Ardekani
Department of Therapeutic Proteins, CBER, FDA, Bethesda, MD 20892, USA
Expert Rev Mol Diagn 3:129-40. 2003....
- Informed consent and investigational new drug abuses in the U.S. militaryMary L Cummings
Systems Engineering, University of Virginia, PO Box 400747, Charlottesville, VA 22904 4747, USA
Account Res 9:93-103. 2002....
- America's other drug problem: how the drug industry distorts medicine and politicsArnold S Relman
Harvard Medical School, USA
New Repub 227:27-41. 2002
- Pharmacogenetics: ethical issues and policy optionsAllen Buchanan
Department of Philosophy, University of Arizona, Tucson, AZ, USA
Kennedy Inst Ethics J 12:1-15. 2002..We analyze each of these categories of ethical issues and provide policy approaches for addressing them...
- Nontherapeutic research with children: the virtues and vices of legal uncertaintyDavid M Smolin
Cumberland Law School, Samford University, USA
Cumberland Law Rev 33:621-45. 2002
- When terrorism threatens health: how far are limitations on personal and economic liberties justified?Lawrence O Gostin
Georgetown Univesity, Washington, DC, USA
Fla Law Rev 55:1105-70. 2003
- Ethics, regulation, and biomedical researchMatthew Weed
Yale University, USA
Kennedy Inst Ethics J 14:361-8. 2004....
- The President's Council on Bioethics: my take on some of its deliberationsWilliam F May
Institute for Practical Bioethics and Public Life, University of Virginia, USA
Perspect Biol Med 48:229-40. 2005
- Politics, culture, and the lab: public attitudes toward animals and human embryonic stem cells have fostered different research agendas in Britain and the United StatesAnne Marie Borrego
Chron High Educ 51:A43-5. 2005
- Bush tails follow-onsJeff Fox
Nat Biotechnol 26:366. 2008
- Public health. A case study of personalized medicineS H Katsanis
Genetics and Public Policy Center, Berman Institute of Bioethics corrected, The Johns Hopkins University, Washington, DC 20036, USA
Science 320:53-4. 2008
- A postmodernist take on the human embryo research debateLars Noah
University of Florida, USA
Conn Law Rev 36:1133-61. 2004
- Balancing government regulation against access to drugs: address to Seton Hall University School of Law, February 16, 2007Daniel Meron
United States Department of Health and Human Services, USA
Seton Hall Law Rev 37:929-39. 2007
- Why Ashcroft is wrong on assisted suicideNelson Lund
George Mason University School of Law, USA
Commentary 113:50-5. 2002
- A cognitive scientist looks at DaubertGeorge P Lakoff
1203 Dwinelle Hall, University of California at Berkeley, Berkeley, CA 94720 2650, USA
Am J Public Health 95:S114-20. 2005..Daubert functions in its application as a strategic initiative that significantly moves America in a conservative direction, in the moral and political spheres, as well as in the legal sphere...
- The first pharmacoepidemiologic investigations: national drug safety policy in the United States, 1901-1902David E Lilienfeld
Perspect Biol Med 51:188-98. 2008..That power, welcomed by manufacturers to restore the public's trust in their products, was enhanced in the 1906 Food and Drug Act, which created the Food and Drug Administration...
- Human research protections: time for regulatory reform?Karen J Maschke
Hastings Cent Rep 38:19-22. 2008
- CELL SURFACE STRUCTURE AND TRANSFORMATIONSRichard Hynes; Fiscal Year: 2005..Evaluation of the functions of cell adhesion proteins and the consequences of their misexpression in metastatic cells will lead to new leads for therapeutic interventions against metastasis. ..
- Youth Alcohol, Tobacco and Marijuana Use: Effects of Hours of Work and WagesRobert Kaestner; Fiscal Year: 2009..The proposed research will identify the importance of employment and earned income on youth substance use and produce information that can be used to design effective public health policy to address this problem. ..
- Hospice Enrollment and LTC Policy (HELP)Susan Miller; Fiscal Year: 2007..unreadable] [unreadable] [unreadable]..
- Youth Support Team Intervention for Suicidal AdolescentsCheryl King; Fiscal Year: 2006..abstract_text> ..
- DEMOLITION AND ASTHMA IN CHICAGO PUBLIC HOUSINGSamuel Dorevitch; Fiscal Year: 2006....
- Views of Privacy of Genetic InformationRobert Klitzman; Fiscal Year: 2005..The findings of this study can enhance further policy, professional and public education, and future research in this area. ..
- Views and Approaches Toward Research Integrity Among IRBsRobert Klitzman; Fiscal Year: 2007..We anticipate that the data from this study will serve as a significant foundation in assisting future research and the improvement of Rl through guidelines, education and other capacity building. [unreadable] [unreadable] [unreadable]..
- Innovative Interventions for Smoking CessationDorothy K Hatsukami; Fiscal Year: 2010..The results of this study will provide useful information on directions to pursue to improve our pharmacotherapies and behavioral treatments and to better understand the various aspects of addiction. ..
- TOBACCO EXPOSURE REDUCTIONDorothy Hatsukami; Fiscal Year: 2008..The results of research from this TTURC will provide the scientific basis for urgent policy, public education, and regulatory efforts to reduce tobacco harm. ..
- TREATMENT OF SMOKELESS TOBACCO USERSDorothy Hatsukami; Fiscal Year: 2008..PERFORMANCE SITE ========================================Section End=========================================== ..
- Research Integrity & Financial Conflicts of InterestPatricia Tereskerz; Fiscal Year: 2004..4) Explore the utility of using data reduction techniques and appropriate, multi-variate modeling techniques to show which types of financial arrangements predict questionable integrity practices. ..
- Interventions for Tobacco Dependent AdolescentsDorothy Hatsukami; Fiscal Year: 2005....
- Evaluating Low Ignition Propensity Cigarette LegislationRICHARD O CONNOR; Fiscal Year: 2009..Taken together, these studies comprise a comprehensive evaluation of the potential impacts of this harm-reduction policy, which will inform policymakers in other jurisdictions considering similar regulations. ..
- Clinical Supervision and Turnover in Substance Abuse TxLillian T Eby; Fiscal Year: 2010..This project responds to program announcement PA-03-011 "Services Research in the National Drug Abuse CTN". Substance abuse treatment centers that are affiliated with the Clinical Trails Network will provide data for the project. ..
- NEWBORN GENETIC SCREENING:FOR WHOSE BENEFIT?Lainie Ross; Fiscal Year: 2005..OUTCOMES: The major outcomes will be a series of peer-reviewed articles and a full-length book entitled Newborn Genetic Screening: In whose Interest? For whose Benefit? ..
- National Black Leadership Conference on GeneticsKathy Hudson; Fiscal Year: 2004..The Conference will be held in Washington DC in May 2004. ..
- Impact of Poor Health & AIDS on Small Businesses in SAMark Pauly; Fiscal Year: 2003..They will be useful for predicting the effect of changes in health on economic activity in this sector, and for allocating resources for disease prevention and treatment. ..
- Back Disorders in Union CarpentersHester Lipscomb; Fiscal Year: 2006..The project addresses a number of areas of expressed interest to NIOSH including construction workers, back disorders, surveillance methods and health services research. [unreadable] [unreadable]..
- Effect of 14 Underage Drinking Laws on Youthful DeathsJames Fell; Fiscal Year: 2006..abstract_text> ..
- Capacity to Appoint a Proxy for Research ConsentScott Kim; Fiscal Year: 2009..abstract_text> ..
- Lifetime body weight and premenopausal breast cancerKARIN MICHELS; Fiscal Year: 2008..unreadable] [unreadable] [unreadable] [unreadable] [unreadable] [unreadable] [unreadable] [unreadable] [unreadable] [unreadable] [unreadable] [unreadable] [unreadable] [unreadable] [unreadable] [unreadable] [unreadable] [unreadable]..
- Competence to Consent in Schizophrenia ResearchScott Kim; Fiscal Year: 2005..abstract_text> ..
- Risks for HIV and STIs among Moscow Sex WorkersChris Beyrer; Fiscal Year: 2005..abstract_text> ..
- Racial Disparity in Access High Quality Cardiac SurgeonsDana Mukamel; Fiscal Year: 2005..The knowledge gained in this project is essential for development of targeted programs that could successfully address the disparity in access to high quality cardiac care among elderly racial minorities. ..
- Stem Cell Based Soft Tissue ReconstructionJeremy J Mao; Fiscal Year: 2010..An interdisciplinary team of biomedical engineers, biologists, biomaterial scientists, imaging scientists and surgical consultants have been assembled to meet the challenges of realizing our goals. ..
- Community Environmental Health Research: Finding MeaningDavid Ozonoff; Fiscal Year: 2006..4) Establish mechanisms for forging new and on-going community-researcher relationships. ..
- Developing Probiotics as Foods and Drugs - Scientific and Regulatory ChallengesPatricia Hibberd; Fiscal Year: 2006..An NIH Conference Grant is being requested for supplemental funding to support the travel of key US based workshop faculty and support of publication expenses. [unreadable] [unreadable] [unreadable] [unreadable]..
- CLINICAL RESEARCH TRAINING PROGRAMJack Zwanziger; Fiscal Year: 2008..abstract_text> ..
- Imaging of nicotine sensitization in humans: a translational application of fMRIJoseph DiFranza; Fiscal Year: 2008..The long-term goal is to use this new tool to see how addictive drugs alter the brain, and thereby identify targets for the development of new drugs to treat addiction. [unreadable] [unreadable] [unreadable]..
- Nursing Homes Response to Quality Indictors PublicationDana Mukamel; Fiscal Year: 2008..Statistical regression techniques will be used to analyze the data and test specific hypotheses. ..
- Screening for Colorectal Cancer: An Integrated ApproachKathryn Phillips; Fiscal Year: 2007..We will focus particularly on the influence of (a) utilization rates (Aim #1) and (b) patient preferences for current and new screening methods (Aim #2). ..
- ALPHA 2 ADRENERGIC CONTROL IN IRRITABLE BOWEL SYNDROMEMichael Camilleri; Fiscal Year: 2008..Significance: This project will characterize pharmacogenetic mechanisms determining the response to clonidine through studies of candidate genes that control alpha2-adrenoreceptor function and norepinephrine transport in IBS. ..
- Simplified Tai Chi for Reducing Fibromyalgia PainCHRISTY SHERMAN; Fiscal Year: 2007..unreadable] [unreadable] [unreadable]..
- Nursing Homes Quality and Variations in State RegulationsDana B Mukamel; Fiscal Year: 2010..S. population. ..
- Transdisciplinary and Multilevel Approaches in Health Behavior ResearchR Scott Olds; Fiscal Year: 2006..unreadable] [unreadable] [unreadable] [unreadable]..
- Parental Time, Income and Children's BMIBisakha Sen; Fiscal Year: 2007..Finally, data from the Consumer Expenditure Survey (CES) will be used to investigate the effects of parental time and income on the family's patterns of food purchases. [unreadable] [unreadable] [unreadable]..
- Wage Mandate, Labor Turnover, and NH QualityVincent Mor; Fiscal Year: 2007..5) Use the theoretical model to assess the relative merits of alternative minimum nurse staffing and wage policies in terms of their relative cost and effectiveness. ..
- Colliding Categories: Haplotypes, Race & EthnicityJonathan Kahn; Fiscal Year: 2003..The project will disseminate its findings through a consensus article, web-based materials, a national conference to be held during its second year, and a published symposium growing out of that conference. ..
- METHODOLOGIC ISSUES IN NUTRITIONAL EPIDEMIOLOGYKARIN MICHELS; Fiscal Year: 2002..We aim to provide guidance to researchers who wish to explore diet-disease relations in how to use data best to obtain most valid results and avoid pitfalls which might produce misleading associations. ..
- Hangover, Congeners, Sleep and Occupational PerformanceJonathan Howland; Fiscal Year: 2004..Our occupational model will be merchant ship navigation by maritime academy cadets. Performance will be measured using computer-based interactive ship training simulators. ..
- SHORT WAVELENGTH AUTOMATED PERIMETRY IN THE OHTS TRIALChris Johnson; Fiscal Year: 2004..Additionally, the prevalence of SWAP deficits in African American patients participating in OHTS will be evaluated to determine whether African-American ocular hypertensives have a higher prevalence of SWAP deficits. ..
- SECONDARY PREVENTION TRIAL OF VENOUS THROMBOSISPaul Ridker; Fiscal Year: 2002....
- MORTALITY FOLLOW-UP AND ANALYSES OF MEN IN THE MRFITJames Neaton; Fiscal Year: 2005..These and six other secondary aims will take full advantage - in a highly effective way - of the unique high quality data sets for the two MRFIT cohorts. ..
- Collaborative IRB Mentoring ProjectRoberto Rivera; Fiscal Year: 2003..Establish a collaborative and mutually strengthening program between the African IRBs and FHI's IRB. . Create a program of IRB development that can be replicated. ..
- Nanostenting Hydrogels for Sinus SurgeryRICHARD ORLANDI; Fiscal Year: 2004..The results of these Phase I studies will determine the feasibility and the optimal chemical properties of a nanostenting HA gel for human trials. ..
- USE OF CANCER SCREENING IN A MANAGED CARE ENVIRONMENTKathryn Phillips; Fiscal Year: 2002..The findings will therefore have implications not only for the types of screening examined in this study but also for other health care services. ..
- TERRY BEIRN COMMUNITY PROGRAMS FOR CLINICAL RESEARCH ONJames Neaton; Fiscal Year: 2006..abstract_text> ..
- STATISTICAL METHODOLOGY FOR CANCER CLINICAL TRIALSWILLIAM ROSENBERGER; Fiscal Year: 2004..Finally, we develop user-friendly front-end software to facilitate the conduct of phase I clinical trials in Specific Aim VII. ..
- Barriers to Enrolling the Elderly in Cancer TrialsCary Gross; Fiscal Year: 2004..It is our hope that this work will facilitate the development of targeted and novel approaches to overcoming these barriers. ..
- Exception from informed consent in pediatricsMarilyn Morris; Fiscal Year: 2007..unreadable] [unreadable]..
- WORK AND HEALTH DISPARITIES AMONG RURAL WOMENHester Lipscomb; Fiscal Year: 2004..Education will also be targeted to medical providers in this geographic area on work exposures and conditions, exposure response, prevention, basic epidemiology, and ergonomics. ..
- The Molecular Basis of Ovarian Testosterone ProductionRobert Rosenfield; Fiscal Year: 2004..The overall goal of this proposal is to understand the factors regulating the production of testosterone in women, particularly in their ovaries. ..
- Tobacco CarcinogenesisStephen Hecht; Fiscal Year: 2005..Steven Tannenbaum (MIT), Dr. Jack Henningfield (Johns Hopkins and Pinney Associates), Drs. Jeffrey Seeman and Anthony Tricker (Philip Morris), and Dr. John Lauterbach (an independent consultant, formerly with Brown and Williamson). ..
- Ethics of Surrogate Consent for Dementia ResearchScott Y Kim; Fiscal Year: 2010....
- Implementation of Asthma Guidelines in Primary Care; Comparison of 4 approachesJames W Mold; Fiscal Year: 2010..If effective, the same strategies could be used to facilitate implementation of other chronic disease guidelines. ..
- Cannabinoid Mechanisms in Human Gastrointestinal Motor and Sensory FunctionsMICHAEL L CAMILLERI; Fiscal Year: 2010..These actions may be relevant to develop new treatments for IBS. The studies will also provide further understanding of the potential of medications like medical marijuana on stomach function that may be relevant to appetite control. ..
- Effects of Dioxin on Vietnamese CiviliansDavid Carpenter; Fiscal Year: 2004..7. ..
- State Policies and Hospitalizations from Nursing HomesVincent Mor; Fiscal Year: 2004..These theoretical insights will help shape the policy implications emerging from the study. ..
- ERYTHROCYTAPHERESIS TO LOWER IRON LOADING IN THALASSEMIAAlan Cohen; Fiscal Year: 2002....
- Stem-Cell Based Tissue Engineering in Regenerative Medicine ConferenceJeremy Mao; Fiscal Year: 2006..abstract_text> ..
- Providers' perceptions of the diaphragm in Southern Afr*Cynthia Harper; Fiscal Year: 2005..As the diaphragm effectiveness results become available, data from this proposed study will position us to design counseling interventions and to address provider education and training needs. ..
- LONGITUDINAL ORAL HEALTH OUTCOMES IN HIGH-RISK ADULTSGREGG GILBERT; Fiscal Year: 2003....
- Suicidality in Schizophrenia: Risk & Protective FactorsDEQUINCY LEZINE; Fiscal Year: 2004..abstract_text> ..
- Impact of Changing Medicaid Policies on NH QualityVincent Mor; Fiscal Year: 2006..abstract_text> ..
- Mid-Career Investigator Award-Patient-Oriented ResearchGREGG GILBERT; Fiscal Year: 2005....
- SAFEHAVEN: Decision Support for Nursing Home Resident Disaster EvacuationsVincent Mor; Fiscal Year: 2010..Using existing nursing home data from multiple sources, this study seeks to understand the consequences of hurricanes and evacuation decisions, providing the first evidence base to inform the creation of evacuation guidelines. ..
- UAB Oral Health Research Infrastructure ImprovementGREGG GILBERT; Fiscal Year: 2003..abstract_text> ..
- Welfare Reform, Fertility and Reproductive BehaviorRobert Kaestner; Fiscal Year: 2003....
- Oral Health/OHRQOL among low-SES rural adultsGREGG GILBERT; Fiscal Year: 2004....
- DO GOOD NURSING HOMES ACHIEVE GOOD OUTCOMES?Vincent Mor; Fiscal Year: 2003..This latter exploratory data analysis step is crucial to derive from the theoretical results insights about how to intervene in a nursing home to improve the chance of achieving positive outcomes. ..
- Alabama Dental Practice Research Network DevelopmentGREGG GILBERT; Fiscal Year: 2005..abstract_text> ..
- The Spillover Effects of Health Insurance Coverage and GenerosityKatherine Baicker; Fiscal Year: 2008..unreadable] [unreadable] [unreadable]..
- Pharmacotherapy for Minor DepressionRobert Howland; Fiscal Year: 2004..The results of this study will have profound public health implications by improving our understanding of the efficacy of SJW and standard antidepressants for the treatment of MinorD. ..
- UAB Oral Health Research InnovationGREGG GILBERT; Fiscal Year: 2005..abstract_text> ..